{"id":334948,"date":"2026-11-02T14:50:38","date_gmt":"2026-11-02T09:20:38","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=334948"},"modified":"2026-11-02T14:50:38","modified_gmt":"2026-11-02T09:20:38","slug":"specialty-performance-chemicals-maker-contract-drug-maker-and-active-ingredients-and-formulations-company-stocks-roadmap-ridgeline-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/specialty-performance-chemicals-maker-contract-drug-maker-and-active-ingredients-and-formulations-company-stocks-roadmap-ridgeline-list\/","title":{"rendered":"3 Specialty Performance Chemicals Maker, Contract Drug Maker and Active Ingredients and Formulations Company Stocks With a Strong Future Roadmap: Clean Science and Technology, Innova Captab and Laurus Labs"},"content":{"rendered":"

Clean Science and Technology, Innova Captab and Laurus Labs: ROE of 12.9% to 16.8% and FY22 to FY26 revenue CAGR of 8.5% to 19.5%. Prices as of 30 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three specialty chemical, contract drug and API stocks to watch are Clean Science and Technology, Innova Captab and Laurus Labs. Their return on equity ranges from 12.9% to 16.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.5% to 19.5%. Laurus Labs has the highest return on equity at 16.8%, while Innova Captab has the fastest revenue growth at 19.5% a year. Prices are based on the 30 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Specialty chemical, contract drug and API stocks offer a focused view of a sector where demand keeps widening. Clean Science and Technology, Innova Captab and Laurus Labs cover a specialty performance chemicals maker, a contract drug maker and an active ingredients and formulations company.<\/p>\n

This list covers three specialty chemical, contract drug and API stocks with complete current figures: Clean Science and Technology, Innova Captab and Laurus Labs. Every figure comes from the latest reported financials and the 30 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n